Please login to the form below
Video: Immuno-oncology therapies
Immuno-oncology therapies which harness the body’s own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment. However, these therapies come with a very high price tag and currently only a few of these drugs have actually reached the market including Opdivo, Keytruda and Yervoy. In this video Director Sue Marett discusses the opportunities and challenges for new immuno-oncology therapies and outlines what these mean for pharma market research.
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
http://www.researchpartnership.com/news/2016/05/video-immuno-oncology-therapies/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Interactive infographic
- Living With: The journey from the patient’s perspective
Research Partnership
- Article: Spotlight on Mexico
- Healthcare under AMLO – One year on
Research Partnership
- News: Mandira Kar joins London Headquarters as Qualitative Research Director
Research Partnership
- Conference Live
- Global medical conferences and events calendar 2020
Research Partnership
- Announcing a change of leadership at the US Philadelphia office
Research Partnership
- Article: Market access in Brazil
- All eyes on Spinraza
Research Partnership
